Willenbring Robin C, Johnson Aaron J
Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA.
Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Int J Mol Sci. 2017 Jul 25;18(8):1608. doi: 10.3390/ijms18081608.
Perforin is critical for controlling viral infection and tumor surveillance. Clinically, mutations in perforin are viewed as unfavorable, as lack of this pore-forming protein results in lethal, childhood disease, familial hemophagocytic lymphohistiocytosis type 2 (FHL 2). However, many mutations in the coding region of are not yet associated with disease. Animal models of viral-associated blood-brain barrier (BBB) disruption and experimental cerebral malaria (ECM) have identified perforin as critical for inducing pathologic central nervous system CNS vascular permeability. This review focuses on the role of perforin in both protecting and promoting human disease. It concludes with a novel hypothesis that diversity observed in the gene may be an example of selective advantage that protects an individual from perforin-mediated pathology, such as BBB disruption.
穿孔素对于控制病毒感染和肿瘤监测至关重要。在临床上,穿孔素的突变被视为不利因素,因为缺乏这种形成孔道的蛋白质会导致致命的儿童疾病——2型家族性噬血细胞性淋巴组织细胞增生症(FHL 2)。然而,穿孔素编码区域的许多突变尚未与疾病相关联。病毒相关血脑屏障(BBB)破坏和实验性脑疟疾(ECM)的动物模型已确定穿孔素对于诱导病理性中枢神经系统(CNS)血管通透性至关重要。本综述重点关注穿孔素在保护和促发人类疾病中的作用。最后提出了一个新的假说,即穿孔素基因中观察到的多样性可能是一种选择性优势的例子,这种优势可保护个体免受穿孔素介导的病理影响,如血脑屏障破坏。